The Long-Term Effect of Early Anti-Tumor Necrosis Factor on Restoration of Growth in Pediatric Crohn’s Disease

참고문헌 (10)

1. Ley D, "Growth pattern in paediatric Crohn disease is related to inflammatory status", J Pediatr Gastroenterol Nutr, 63, pp.637~643 (2016)[DOI]
2. Griffin LM, "Improvements in bone density and structure during anti-TNF-alpha therapy in pediatric Crohn's disease", J Clin Endocrinol Metab, 100, pp.2630~2639 (2015)[DOI]
3. 이은주, "Effect of the Baseline Vitamin D Level on Growth Outcome in Pediatric Crohn Disease", Pediatric Gastroenterology, Hepatology & Nutrition, 20(1), pp.41~46 (2017), 대한소아소화기영양학회
4. Cameron FL, "Disease status and pubertal stage predict improved growth in antitumor necrosis factor therapy for pediatric inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 64, pp.47~55 (2017)[DOI]
5. Hyams J, "Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children", Gastroenterology, 132, pp.863~873 (2007)[DOI]
6. Hyams J, "Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension", Curr Med Res Opin, 27, pp.651~662 (2011)[DOI]
7. Thayu M, "Determinants of changes in linear growth and body composition in incident pediatric Crohn's disease", Gastroenterology, 139, pp.430~438 (2010)[DOI]
8. Ruemmele FM, "Consensus guidelines of ECCO", ESPGHAN on the medical management of pediatric Crohn's disease, 2014, pp.8, 1179~1207
9. Church PC, "Infliximab maintains durable response and facilitates catch-up growth in luminal pediatric Crohn's disease", Inflamm Bowel Dis, 20, pp.1177~1186 (2014)[DOI]
10. Jaeyoung Choi, "Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn’s Disease Patients", Gut and Liver, 12(3), pp.255~262 (2018), 거트앤리버 소화기연관학회협의회

관련 논문AI추천